Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience

• Autors principals: Szabolcs Szatmári (Autor), József Attila Szász (Autor), Károly Orbán-Kis (Autor), Beáta Baróti (Autor), Simona Bataga (Autor), Marius Ciorba (Autor), Előd Ernő Nagy (Autor), Radu Mircea Neagoe (Autor), István Mihály (Autor), Péter Zsombor Szász (Autor), Krisztina Kelemen (Autor), Attila Frigy (Autor), Mónika Szilveszter (Autor), Viorelia Adelina Constantin (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2024-03-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Levodopa-entacapone-carbidopa intestinal gel infusion is a relatively new treatment option for advanced Parkinson's disease. We aimed to describe and analyze the characteristics of de novo levodopa-entacapone-carbidopa intestinal gel therapy in 20 consecutive patients with advanced Parkinson�...